7Baggers

Exact Sciences Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -876.35-635.29-394.23-153.1687.9328.96570.02811.09Milllion

Exact Sciences Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2009-06-30 2009-03-31 2008-09-30 2008-06-30 2008-03-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-09-30 2004-06-30 2004-03-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2002-02-10 2001-12-31 2001-09-30 2001-06-30 2000-12-31 
                                                                                            
  revenue811,085,000 706,785,000 713,424,000 708,655,000 699,264,000 637,524,000 646,885,000 628,338,000 622,093,000 602,450,000 552,995,000 523,073,000 521,640,000 486,571,000 473,812,000 456,379,000 434,819,000 402,077,000 466,339,000 408,363,000 268,868,000 347,821,000 295,575,000 218,805,000 199,870,000 162,043,000                                                      406,000 408,000 122,175.25 409,479 39,956 39,266 39,956 3,272.25 13,089   
  yoy15.99% 10.86% 10.29% 12.78% 12.41% 5.82% 16.98% 20.12% 19.26% 23.82% 16.71% 14.61% 19.97% 21.01% 1.60% 11.76% 61.72% 15.60% 57.77% 86.63% 34.52% 114.65%                                                          916.12% 939.07% 205.77% 12413.68% 205.26%       
  qoq14.76% -0.93% 0.67% 1.34% 9.68% -1.45% 2.95% 1.00% 3.26% 8.94% 5.72% 0.27% 7.21% 2.69% 3.82% 4.96% 8.14% -13.78% 14.20% 51.88% -22.70% 17.68% 35.09% 9.47% 23.34%                                                       -0.49% 233.95% -70.16% 924.82% 1.76% -1.73% 1121.06% -75.00%    
  cost of sales248,632,000 206,238,000 284,131,000 196,070,000 189,848,000 170,101,000 171,865,000 168,526,000 156,991,000 156,866,000 147,152,000 147,937,000 144,600,000 134,705,000 119,058,000 115,738,000 113,968,000 109,993,000 99,765,000 95,061,000 77,892,000 81,606,000 69,143,000 52,759,000 51,563,000 43,252,000 38,160,000 30,020,000 26,888,000 22,914,000 23,495,000 20,729,000 17,991,000 16,981,000 13,865,000 12,174,000 10,097,000 9,059,000 7,667,000 7,528,000 5,094,000 4,212,000 3,401,000 924,000                                               
  gross profit562,453,000 500,547,000                                                1,036,000 1,036,000 1,036,000 1,033,000 1,036,000 1,034,000 1,350,000 1,308,000 1,293,000 1,251,000 1,250,000 1,000,000   50,000 67,000 1,114,000 1,168,000 1,154,000 1,053,000 1,128,000 606,000 -2,549,316 863,000 491,000 1,199,000 1,038,000 1,162,000 1,145,000 905,000  405,000 120,566.5 405,321        
  yoy                                                 0.00% 0.19% -23.26% -21.02% -19.88% -17.35% 8.00% 30.80%   2400.00% 1392.54%   -95.67% -93.64% -1.24% 92.74% -145.27% 22.02% 129.74% -49.46% -345.60% -25.73% -57.12% 32.49%  186.91% 849.68% 123.28%            
  qoq12.37%                                                 0.00% 0.00% 0.29% -0.29% 0.19% -23.41% 3.21% 1.16% 3.36% 0.08% 25.00%    -25.37% -93.99% -4.62% 1.21% 9.59% -6.65% 86.14% -123.77% -395.40% 75.76% -59.05% 15.51% -10.67% 1.48% 26.52%   235.91% -70.25%         
  gross margin %69.35% 70.82% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%                                                      0% 99.26% 98.68% 98.98% 0% 0% 0% 0% 0%   
  operating expenses                                                                                          
  research and development108,901,000 105,310,000 99,617,000 100,101,000 120,884,000 110,608,000 114,922,000 111,446,000 104,095,000 95,419,000 94,274,000 90,813,000 106,083,000 102,248,000 88,488,000 75,356,000 106,235,000 115,567,000 446,399,000 31,471,000 32,673,000 43,509,000 42,530,000 34,945,000 30,203,000 32,016,000 20,932,000 17,631,000 14,712,000 14,935,000 12,675,000 11,725,000 9,737,000 8,002,000 7,082,000 7,625,000 8,640,000 10,126,000 9,365,000 9,863,000 8,115,000 6,571,000 4,992,000 9,073,000 7,174,000 7,430,000 6,982,000 6,457,000 7,526,000 10,491,000 12,202,000 8,999,000 6,110,000 5,197,000 2,989,000 2,635,000 2,123,000 1,795,000 837,000 2,015,000 108,000 577,000 528,000 859,000 1,009,000 1,332,000 1,277,000 1,152,000 1,705,000 1,918,000 1,960,000 -6,085,157 1,937,000 1,875,000 2,281,000 2,518,000 2,640,000 3,134,000 4,312,000 4,592,000 5,013,000 3,809,827 5,130,706 5,065,822 5,042,780 5,065,822 2,231,847.5 3,535,013 2,849,562  
  sales and marketing247,118,000 264,310,000 321,837,000 194,653,000 185,270,000 192,365,000 190,477,000 173,159,000 176,490,000 186,964,000 210,211,000 187,697,000 215,922,000 232,181,000 284,304,000 196,617,000 194,827,000 186,141,000 166,827,000 136,481,000 118,862,000 167,749,000 119,851,000 86,196,000 88,190,000 90,939,000 76,773,000 64,836,000 54,431,000 53,408,000 40,627,000 37,768,000 36,728,000 38,801,000 30,506,000 26,308,000 30,301,000 25,711,000 21,944,000 23,079,000 20,593,000 16,524,000 15,069,000 13,217,000 6,166,000 4,456,000 1,615,000 3,302,000 1,759,000 1,006,000 1,331,000 594,000 815,000 651,000 297,000 315,000 330,000 109,000 12,000 40,000     385,000 510,000 495,000 624,000 1,051,000 1,272,000 1,486,000 -4,403,382 1,191,000 1,619,000 1,599,000                
  general and administrative208,582,000 220,686,000 119,651,000 217,201,000 201,856,000 243,117,000 220,551,000 217,393,000 237,965,000 217,295,000 193,894,000 191,968,000 181,672,000 169,770,000 179,365,000 186,541,000 167,629,000 267,727,000 145,451,000 115,589,000 106,685,000 113,991,000 144,124,000 80,565,000 63,734,000 64,030,000 56,432,000 46,729,000 39,565,000 35,567,000 33,598,000 30,763,000 24,609,000 20,070,000 21,498,000 20,292,000 17,284,000 17,824,000 15,864,000 15,432,000 13,683,000 12,971,000 10,625,000 8,994,000 6,230,000 4,586,000 3,686,000 3,628,000 2,648,000 2,547,000 2,393,000 2,145,000 1,951,000 1,830,000 2,150,000 1,796,000 1,339,000 1,512,000 1,478,000 1,638,000 4,768,000 1,271,000 1,495,000 1,835,000 2,290,000 1,337,000 1,542,000 1,431,000 1,700,000 1,497,000 1,641,000 -3,768,274 1,395,000 1,157,000 1,221,000         427,026  427,026 573,390.25 654,085 2,606,416  
  impairment of long-lived and indefinite-lived assets 6,251,000                                                                                         
  total operating expenses564,601,000 596,557,000 752,193,000 751,158,000 729,321,000 743,948,000 721,126,000 693,516,000 699,022,000 679,541,000 671,877,000 647,887,000 681,224,000 663,558,000 695,262,000 618,402,000 606,483,000 702,618,000 881,641,000 611,698,000 359,542,000 430,194,000 539,257,000 201,706,000 182,127,000 186,985,000 154,137,000 129,196,000 108,708,000 103,910,000 86,900,000 80,256,000 71,074,000 66,873,000 59,086,000 54,225,000 56,225,000 53,661,000 47,173,000 48,374,000 42,391,000 36,066,000                                                 
  other operating income  2,568,000 3,100,000 3,800,000 -268,000 6,400,000 72,027,000    -13,244,000         23,665,000                                                                      
  income from operations-2,148,000 -96,010,000 -876,351,000 -39,403,000 -26,257,000 -106,692,000 -67,841,000 6,849,000 -76,929,000 -77,091,000 -118,882,000 -138,058,000 -159,584,000 -176,987,000 -221,450,000 -162,023,000 -171,664,000 -300,541,000 -415,302,000 -203,335,000 -67,009,000 -82,373,000 -96,108,000 -35,660,000 -33,820,000 -68,194,000 -49,316,000 -40,925,000 -32,702,000 -36,528,000 -22,989,000 -28,411,000 -31,419,000 -35,491,000 -37,710,000 -38,284,000 -45,137,000 -47,885,000 -40,420,000 -43,270,000 -39,366,000 -36,012,000                                                 
  yoy-91.82% -10.01% 1191.77% -675.31% -65.87% 38.40% -42.93% -104.96% -51.79% -56.44% -46.32% -14.79% -7.04% -41.11% -46.68% -20.32% 156.18% 264.85% 332.12% 470.20% 98.13% 20.79% 94.88% -12.86% 3.42% 86.69% 114.52% 44.05% 4.08% 2.92% -39.04% -25.79% -30.39% -25.88% -6.70% -11.52% 14.66% 32.97%                                                     
  qoq-97.76% -89.04% 2124.07% 50.07% -75.39% 57.27% -1090.52% -108.90% -0.21% -35.15% -13.89% -13.49% -9.83% -20.08% 36.68% -5.62% -42.88% -27.63% 104.25% 203.44% -18.65% -14.29% 169.51% 5.44% -50.41% 38.28% 20.50% 25.15% -10.47% 58.89% -19.08% -9.57% -11.47% -5.88% -1.50% -15.18% -5.74% 18.47% -6.59% 9.92% 9.31%                                                  
  operating margin %-0.26% -13.58% -122.84% -5.56% -3.75% -16.74% -10.49% 1.09% -12.37% -12.80% -21.50% -26.39% -30.59% -36.37% -46.74% -35.50% -39.48% -74.75% -89.06% -49.79% -24.92% -23.68% -32.52% -16.30% -16.92% -42.08%                                                        0%     0%    
  other income                                                                                          
  investment income11,926,000 4,997,000 9,962,000 11,582,000 11,801,000 6,213,000 25,330,000 2,065,000 4,828,000 490,000 -5,635,000 -8,584,000 -3,719,000 -1,487,000 1,254,000 -4,093,000 3,429,000 31,188,000 1,365,000 2,523,000 2,912,000 97,000 3,113,000 9,093,000 7,669,000 6,655,000 6,321,000 6,292,000 4,917,000 3,673,000 1,320,000 1,334,000 683,000 595,000 592,000 535,000 425,000 466,000 491,000 365,000 193,000 222,000 150,000 160,000 146,000 86,000 103,000 55,000 62,000 67,000 59,000                                        
  interest income-9,835,000    111,000 -7,943,000    4,107,000                         -40,250 -54,000 -53,000  14,000 -40,000 107,000           62,000 75,000 22,000 29,000 14,000 7,000  35,000 49,000 34,000 36,000 64,000 124,000 210,000 238,000 259,000 301,000 320,000 313,000 318,000 -795,886 290,000 261,000 246,000 177,000 172,000 118,000 103,000 126,000 167,000 189,499.5 251,312 231,455 275,231 231,455 550,127.5 623,128 799,725  
  total other income2,091,000 -4,981,000 385,000 1,975,000 11,912,000 -1,730,000 17,465,000 -5,806,000 -2,990,000 4,597,000 -11,045,000 -13,819,000 -8,230,000 -5,965,000 -3,404,000 -8,773,000 -1,223,000 26,572,000 -22,971,000 -21,059,000 -20,000,000 -25,056,000 -10,575,000 -4,116,000 -5,043,000 -15,335,000 -4,651,000 -4,412,000 -3,686,000 -2,837,000 1,269,000 1,283,000 629,000 545,000 540,000 481,000 372,000 412,000 429,000 325,000 300,000 211,000                                                 
  net income before tax-57,000 -100,991,000 -875,966,000 -37,428,000 -14,345,000 -108,422,000 -50,376,000 1,043,000 -79,919,000 -72,494,000 -129,927,000 -151,877,000 -167,814,000 -182,952,000 -224,854,000 -170,796,000 -172,887,000 -273,969,000 -438,273,000 -224,394,000 -87,009,000 -107,429,000 -106,683,000 -39,776,000 -38,863,000 -83,529,000 -53,967,000 -45,337,000 -36,388,000 -39,365,000 -21,720,000 -27,128,000                                                           
  income tax expense-1,128,000 -224,000 -1,019,250 -808,000 -1,463,000 -1,806,000                        -59,000                                                             
  net income-1,185,000 -101,215,000 -864,585,000 -38,236,000 -15,808,000 -110,228,000 -49,766,000 794,000 -81,026,000 -74,151,000 -127,745,000 -148,761,000 -166,063,000 -180,937,000 -220,611,000 -166,938,000 -176,912,000 -31,164,000 -436,810,000 -219,884,000 -86,142,000 -105,697,000 77,945,000 -40,459,000 -38,420,000 -83,059,000 -53,974,000 -45,364,000 -36,387,000 -39,424,000 -21,764,000 -26,897,000 -30,790,000 -34,946,000 -37,170,000 -37,803,000 -44,765,000 -47,473,000 -39,991,000 -42,945,000 -39,066,000 -35,801,000 -32,444,000 -32,060,000 -19,437,000 -16,107,000 -11,160,000 -12,314,000 -10,854,000 -12,952,000 -14,836,000 -10,645,000 -7,773,000 -6,625,000 -4,373,000 -3,382,000 -2,477,000 -2,124,000 -1,041,000 -2,394,000 -3,839,000 -3,014,000 -2,100,000 -2,518,000 -4,195,000 -1,825,000 -1,920,000 -2,423,000 -3,083,000 -3,246,000 -4,163,000 11,810,480 -3,289,000 -3,951,000 -4,585,000 -4,403,000 -4,279,000 -5,291,000 -6,862,000 -7,884,000 -7,883,000 -5,718,584.5 -7,413,676 -7,874,777 -7,585,885 -7,874,777 -4,210,130.25 -5,729,378 -5,710,984  
  yoy-92.50% -8.18% 1637.30% -4915.62% -80.49% 48.65% -61.04% -100.53% -51.21% -59.02% -42.09% -10.89% -6.13% 480.60% -49.49% -24.08% 105.37% -70.52% -660.41% 443.47% 124.21% 27.26% -244.41% -10.81% 5.59% 110.68% 148.00% 68.66% 18.18% 12.81% -41.45% -28.85% -31.22% -26.39% -7.05% -11.97% 14.59% 32.60% 23.26% 33.95% 100.99% 122.27% 190.72% 160.35% 79.08% 24.36% -24.78% 15.68% 39.64% 95.50% 239.26% 214.75% 213.81% 211.91% 320.08% 41.27% -35.48% -29.53% -50.43% -4.92% -8.49% 65.15% 9.38% 3.92% 36.07% -43.78% -53.88% -120.52% -6.26% -17.84% -9.20% -368.24% -23.14% -25.33% -33.18% -44.15% -45.72% -7.48% -7.44% 0.12% 3.92% -27.38% 76.09% 37.45% 32.83%      
  qoq-98.83% -88.29% 2161.18% 141.88% -85.66% 121.49% -6367.76% -100.98% 9.27% -41.95% -14.13% -10.42% -8.22% -17.98% 32.15% -5.64% 467.68% -92.87% 98.65% 155.26% -18.50% -235.60% -292.65% 5.31% -53.74% 53.89% 18.98% 24.67% -7.70% 81.14% -19.08% -12.64% -11.89% -5.98% -1.67% -15.55% -5.70% 18.71% -6.88% 9.93% 9.12% 10.35% 1.20% 64.94% 20.67% 44.33% -9.37% 13.45% -16.20% -12.70% 39.37% 36.95% 17.33% 51.50% 29.30% 36.54% 16.62% 104.03% -56.52% -37.64% 27.37% 43.52% -16.60% -39.98% 129.86% -4.95% -20.76% -21.41% -5.02% -22.03% -135.25% -459.09% -16.76% -13.83% 4.13% 2.90% -19.13% -22.89% -12.96% 0.01% 37.85% -22.86% -5.86% 3.81% -3.67% 87.04% -26.52% 0.32%   
  net income margin %-0.15% -14.32% -121.19% -5.40% -2.26% -17.29% -7.69% 0.13% -13.02% -12.31% -23.10% -28.44% -31.83% -37.19% -46.56% -36.58% -40.69% -7.75% -93.67% -53.85% -32.04% -30.39% 26.37% -18.49% -19.22% -51.26%                                                      -1941.87% -1932.11% -4680.64% -1810.51% -19708.62% -19319.22% -19708.62% -128661.63% -43772.47%   
  net income per share-0.01 -0.54 -4.7 -0.21 -0.09 -0.6 -0.27 -0.45 -0.42 -0.72 -0.84 -0.94 -1.04 -1.29 -0.97 -1.03 -0.18 -2.85 -1.46 -0.58 -0.71 0.62 -0.31 -0.3 -0.66 -0.44 -0.37 -0.3 -0.33 -0.18 -0.23 -0.27 -0.32 -0.33 -0.36 -0.46 -0.49 -0.41 -0.45 -0.44 -0.4 -0.39 -0.39 -0.24 -0.23 -0.16 -0.19 -0.17 -0.21 -0.26 -0.19 -0.15 -0.13 -0.08 -0.08 -0.06 -0.06 -0.03 -0.08 -0.13 -0.11 -0.08 -0.09 -0.16 -0.07 -0.07 -0.09 -0.12 -0.12 -0.16 -0.1 -0.13 -0.15 -0.17 -0.17 -0.16  -0.36 -0.42 -0.42          
  weighted-average common shares outstanding—basic and diluted188,902 186,813 184,197  184,313 182,350 180,144  180,204 178,574 176,351 176,997 176,364 174,417 171,348 171,978 171,494 169,434 151,137 150,155 149,727 148,151 131,257 129,567 129,182 126,248 122,207 122,671 122,129 121,016 115,684 119,215 112,847 110,582 102,335 104,807 97,902 97,246 92,135 94,444 88,919 88,662 80,232 82,941 82,048 70,987  64,699 63,836 60,531 57,037 56,718 52,443 52,010 51,930  39,067 35,607   30,230 27,233 27,175 27,145 27,017 26,880 26,790 26,509 26,562 26,402 26,376 26,270 26,291 26,251 26,203                
  interest expense -9,978,000 -9,577,000 -9,607,000   -7,865,000 -7,871,000 -7,818,000  -5,410,000 -5,235,000 -4,511,000 -4,478,000 -4,658,000 -4,680,000 -4,652,000 -4,616,000 -24,336,000 -23,582,000 -22,912,000 -25,153,000 -13,688,000 -13,209,000 -12,712,000 -21,990,000 -10,972,000 -10,704,000 -8,603,000 -6,510,000 -51,000 -51,000 -54,000 -50,000    -54,000    -11,000                                                 
  amortization of acquired intangible assets  17,764,250 24,435,000 23,311,000 23,311,000 23,311,000 22,992,000 22,929,000 22,928,000 22,914,000 23,526,000 26,356,000 24,654,000 24,047,000 23,940,000 23,824,000 23,190,000 23,199,000 23,430,000 23,430,000 23,339,000                                                                     
  impairment of long-lived assets  7,824,000 18,698,000 8,152,000 4,446,000   552,000 69,000 3,432,000 5,946,000                                                                               
  weighted-average common shares outstanding—basic   184,795    180,649                                                                                   
  weighted-average common shares outstanding—diluted   184,795    184,075                                                                                   
  income tax benefit      610,000 -249,000 -1,107,000 -1,657,000 2,182,000 3,116,000 1,751,000 2,015,000 4,243,000 3,858,000 -4,025,000 242,805,000 1,463,000 4,510,000 867,000 1,732,000 184,628,000 -683,000 443,000 470,000 -7,000 -27,000 1,000  -44,000 231,000                                                           
  intangible asset impairment charge            6,591,000   20,210,000    209,666,000                                                                       
  ​                                                                                          
  gross margin                      108,286,000 166,046,000 148,307,000 118,791,000 104,821,000 88,271,000 76,006,000 67,382,000 63,911,000 51,845,000 39,655,000 31,382,000 21,376,000 15,941,000 11,088,000 5,776,000 6,753,000 5,104,000 3,025,000 54,000                                      406,000    38,051 38,894 38,051     
  operating expenses:                                                                                          
  laboratory service revenue                          77,870,250 118,291,000 102,894,000 90,296,000 87,406,000 72,574,000 57,646,000 48,363,000 35,241,000 28,115,000 21,185,000 14,835,000 14,420,000 12,632,000 8,119,000 4,266,000                                                 
  license fees                                             294,000 1,036,000 1,036,000 1,036,000 1,036,000 1,036,000 1,036,000 1,035,000 1,036,000 1,036,000 1,351,000 1,307,000 1,287,000 1,247,000 1,247,000 993,000 337,000 338,000 338,000 338,000 1,091,000 1,091,000 1,090,000 1,091,000 1,091,000 1,091,000 -2,733,172 1,111,000 498,000 1,128,000 1,128,000 1,129,000 1,128,000 905,000            
  total revenue                                      14,420,000 12,632,000 8,119,000 4,266,000                                                 
  weighted average common shares outstanding—basic and diluted                                              70,559         40,155                                   
  revenue:                                                                                          
  product royalty fees                                                    4,000 6,000 4,000 5,000 7,000 12,000 9,000 11,000 7,000 -1,000,000 -495,000 -292,000 -239,000 19,000 26,000 17,000 40,000 61,000 61,000 -164,794 51,000 46,000 68,000 41,000 35,000 22,000             
  cost of revenue:                                                                                          
  restructuring                                                             539,000   788,000  33,000     -625,374   626,000                
  product                                                              11,000 5,000 14,000 5,000 53,000 73,000 24,000 69,000 42,000 -162,784 33,000 79,000 51,000 92,000 58,000 27,000             
  weighted-average common shares outstanding - basic and diluted                                                          34,932 31,283                26,138  22,949   18,808  18,550,699        
  non-cash stock-based compensation expense included in these amounts are as follows:                                                                                          
  non-cash stock-based compensation expense                                                                                          
  included in these amounts are as follows:                                                                                          
  total                                                                     709  68.5 -81      329 330    544,052  544,052 743,138.5 865,887 1,054,731  
  stock-based compensation                                                                       -273,495  52,000 303,000 154,000 120,000 126,000 329,000 330,000 328,000 413,930.75 543,870  567,801 544,052 743,138.5 865,887 1,054,731  
  the following summarizes the departmental allocation of stock-based compensation:                                                                                          
  cost of revenues:                                                                                          
  selling, general and administrative                                                                           2,946,000 2,853,000 3,294,000 3,229,000 3,494,000 3,114,000 1,804,892.75 2,395,733 2,534,409 2,289,429 2,534,409 1,788,544 1,964,695   
  weighted-average common shares outstanding – basic and diluted                                                                            26,081              
  product revenue                                                                              13,000            
  cost of product revenues                                                                              13,000            
  weighted-average common shares outstanding:                                                                                          
  basic and diluted                                                                              19,024 18,801     18,165,019   17,886,920 17,817,844  
  cost of revenues                                                                                3,000 1,608.75 4,158 1,905 372 1,905     
  net income per share-0.01 -0.54 -4.7 -0.21 -0.09 -0.6 -0.27 -0.45 -0.42 -0.72 -0.84 -0.94 -1.04 -1.29 -0.97 -1.03 -0.18 -2.85 -1.46 -0.58 -0.71 0.62 -0.31 -0.3 -0.66 -0.44 -0.37 -0.3 -0.33 -0.18 -0.23 -0.27 -0.32 -0.33 -0.36 -0.46 -0.49 -0.41 -0.45 -0.44 -0.4 -0.39 -0.39 -0.24 -0.23 -0.16 -0.19 -0.17 -0.21 -0.26 -0.19 -0.15 -0.13 -0.08 -0.08 -0.06 -0.06 -0.03 -0.08 -0.13 -0.11 -0.08 -0.09 -0.16 -0.07 -0.07 -0.09 -0.12 -0.12 -0.16 -0.1 -0.13 -0.15 -0.17 -0.17 -0.16  -0.36 -0.42 -0.42          
  basic and diluted                                                                                 -0.313 -0.4  -0.42 -0.43 -0.263 -0.32 -0.32  
  stock-based compensation                                                                                    544,052       
  basic and diluted                                                                                   -0.43       
  weighted average common shares                                                                                          
  outstanding - basic and diluted                                                                                   18,376,369  18,376,369     
   the following summarizes the departmental allocation of stock-based compensation:                                                                                          
  weighted-average common shares                                                                                          
  pro forma basic and diluted                                                                                      -0.2 -0.27 -0.26  
  excludes non-cash stock-based compensation.                                                                                          
  assumes conversion of all outstanding shares of preferred stock into common stock effective january 1, 2001.                                                                                          
  assumes conversion of all outstanding shares of preferred stock into common stock.                                                                                          
  cash flows from operating activities:                                                                                          
  adjustments to reconcile net income to net cash from operating activities;                                                                                          
  depreciation and amortization                                                                                          
  changes in assets and liabilities:                                                                                          
  prepaid expenses                                                                                          
  accounts payable                                                                                          
  accrued expenses                                                                                          
  net cash from operating activities                                                                                          
  cash flows from investing activities:                                                                                          
  purchases of property and equipment                                                                                          
  increase in patent costs and other assets                                                                                          
  purchase of treasury shares                                                                                          
  net cash from investing activities                                                                                          
  cash flows from financing activities:                                                                                          
  net proceeds from sale of common stock                                                                                          
  net proceeds from sale of convertible preferred stock                                                                                          
  proceeds from exercise of common stock options                                                                                          
  repayment of stock subscription receivable                                                                                          
  net cash from financing activities                                                                                          
  net increase in cash and cash equivalents                                                                                          
  cash and cash equivalents, beginning of period                                                                                          
  cash and cash equivalents, end of period                                                                                          
  supplemental disclosure of non-cash investing and financing activities:                                                                                          
  sale of restricted stock through issuance of notes receivable                                                                                          

We provide you with 20 years income statements for Exact Sciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Exact Sciences stock. Explore the full financial landscape of Exact Sciences stock with our expertly curated income statements.

The information provided in this report about Exact Sciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.